Thus, the enhancement of A2AR signaling may be helpful to treat sleep disorders as well as schizophrenia and other psychotic disorders by overcoming dopaminergic hyperactivity or glutamatergic hypoactivity. This evidence concerns the gene ADORA2A and schizophrenia.